Evidence map›Paper›PMID 33926520›Full record

ArticleDiabetology & metabolic syndrome2021

Hesperidin alleviates insulin resistance by improving HG-induced oxidative stress and mitochondrial dysfunction by restoring miR-149.

Miao Tian, Yu-Bo Han, Cheng-Cheng Zhao, Li Liu, Fu-Li Zhang

Open access · goldAbstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Hesperidin ameliorates HJournal of animal science and biotechnology · 2024
    Article
  13. Review
  14. Bioactivity and mechanisms of flavonoids in decreasing insulin resistance.Journal of enzyme inhibition and medicinal chemistry · 2023
    Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Miao TianHeilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, People's Republic of China.
Yu-Bo HanThe First Department of Cardiovascular, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, No. 26 Heping Road , Xiangfang District, Harbin, 150040, Heilongjiang, People's Republic of China. hanyb1989@163.com.ORCID http://orcid.org/0000-0001-5251-0721
Cheng-Cheng ZhaoHeilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, People's Republic of China.
Li LiuThe First Department of Cardiovascular, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, No. 26 Heping Road , Xiangfang District, Harbin, 150040, Heilongjiang, People's Republic of China.
Fu-Li ZhangSchool of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, People's Republic of China.
Heilongjiang University of Chinese Medicine · CN

Funding

Heilongjiang Postdoctoral Funding Project LBH-Z19212Heilongjiang  Provincial Natural Science Foundation of China LH2020H080Heilongjiang University of Traditional Chinese Medicine Research Funding Project 201818, 2019BS02, 2019TD01National Natural Science Foundation of China 82074346
6 · The paper itself

Abstract

backgroundHesperidin, a natural flavanone, has been proven to have multiple protective effects in diabetic rats, such as antioxidant, anti-inflammatory and anti-apoptotic effects. However, the molecular mechanisms underlying the effects of hesperidin are not well elucidated.

methodsLO2 cells were stimulated with high glucose (HG, 33 mM) for 24 h to establish a model of oxidative stress. Then, cell viability was determined using the MTT assay. The antioxidant activities, including the reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GPx) levels, mitochondrial membrane potential (MMP) and adenosine-triphosphate (ATP) production, were measured with the corresponding kits. The levels of gene expression, protein expression and methylation were detected using qRT-PCR, western blotting and methylation-specific PCR (MSP) assays, respectively.

resultsCompared to the NG treatment, hesperidin treatment increased the viability and improved the oxidative stress, mitochondrial dysfunction and insulin resistance of HG-treated LO2 cells, and these effects were correlated with heightened SOD and GPx activities, increased MMP level and ATP generation, reduced MDA, ROS and glucose levels, and activated GSK3β/AKT and inactivated IRS1 signals. Mechanistically, hesperidin treatment enhanced the miR-149 expression level by reducing its promoter methylation by inhibiting DNMT1. Importantly, knockdown of miR-149 obviously abolished the biological roles of hesperidin.

conclusionsOur findings demonstrated that hesperidin treatment ameliorated HG-induced insulin resistance by reducing oxidative stress and mitochondrial dysfunction partly by suppressing DNMT1-mediated miR-149 silencing.

Indexed as

DiabetesHesperidinInsulin resistancemiR-149Mitochondrial dysfunction

Identifiers

PMID33926520
PMCPMC8082863
OpenAlexW3159563562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.